Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2006 | 09-2006 | 06-2006 | 03-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,870 | -6,780 | -4,630 | -2,300 | -11,760 |
| Depreciation Amortization | 2,520 | 2,210 | 1,830 | 1,120 | 4,920 |
| Other Working Capital | 40 | -160 | -250 | -240 | 80 |
| Other Operating Activity | 2,040 | 1,440 | 830 | 320 | 2,980 |
| Operating Cash Flow | $-4,270 | $-3,290 | $-2,220 | $-1,100 | $-3,780 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -20 | -9 | -9 | -9 | -10 |
| Other Investing Activity | -6,310 | -4,361 | -4,421 | -2,461 | 0 |
| Investing Cash Flow | $-6,330 | $-4,370 | $-4,430 | $-2,470 | $-10 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 4,370 | 2,320 | 990 | 440 | 10,660 |
| Financing Cash Flow | $4,370 | $2,320 | $990 | $440 | $10,660 |
| Beginning Cash Position | 6,870 | 6,870 | 6,870 | 6,870 | 10 |
| End Cash Position | 630 | 1,520 | 1,220 | 3,730 | 6,870 |
| Net Cash Flow | $-6,240 | $-5,350 | $-5,650 | $-3,140 | $6,860 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,270 | -3,290 | -2,220 | -1,100 | -3,780 |
| Free Cash Flow | -4,270 | -3,290 | -2,220 | -1,100 | -3,780 |